Ozanimod

Zeposia 0,92 MG Capsulas Duras

1 mg cápsula duraSpainMarketedAuthorised 24 Jun 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ZeposiaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ozanimod

Zeposia 0,92 MG Capsulas Duras

1 mg cápsula duraSpainMarketedAuthorised 24 Jun 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ZeposiaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Zeposia 0,46 mg capsule, hardNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIG

Zeposia 0,92 mg capsule, hardNetherlands · Capsule, hard · Bristol-Myers Squibb Pharma EEIG

ZeposiaUnited States · 0.23MG BASE, 0.46MG BASE, 0.92MG BASE · capsule · Bristol

OzanimodUnited States · 0.23MG, 0.46MG · capsule · Synthon BV

Packs

Pack	Code	Status
ZEPOSIA 0,92 MG CAPSULAS DURAS 28 cápsulas	728770

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ozanimod
Strength: 1 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 24 Jun 2020
Registration: 1201442002
Marketing authorisation holder: Bristol-Myers Squibb Pharma Eeig
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/20/1442